Xiufeng Ye

776 total citations
23 papers, 624 citations indexed

About

Xiufeng Ye is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xiufeng Ye has authored 23 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Xiufeng Ye's work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (3 papers). Xiufeng Ye is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (3 papers). Xiufeng Ye collaborates with scholars based in China, United States and Hong Kong. Xiufeng Ye's co-authors include Yongying Hou, Weijun Wan, Xia Pu, Ke Wang, Dan Wan, Ke Wang, Wei Shen, Hairong Xu, Bo Sun and Yu Yin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Death and Disease and Biomedicine & Pharmacotherapy.

In The Last Decade

Xiufeng Ye

20 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiufeng Ye China 12 288 114 108 97 94 23 624
Yan Mi China 16 272 0.9× 116 1.0× 86 0.8× 56 0.6× 58 0.6× 41 587
Xiaobo Sun China 12 295 1.0× 121 1.1× 42 0.4× 48 0.5× 98 1.0× 17 603
Jung Seok Hwang South Korea 18 476 1.7× 57 0.5× 135 1.3× 81 0.8× 81 0.9× 51 856
Guo Zu China 16 499 1.7× 66 0.6× 223 2.1× 55 0.6× 173 1.8× 37 929
Zhangping Liao China 19 405 1.4× 35 0.3× 61 0.6× 67 0.7× 104 1.1× 31 821
Xue Dong China 18 509 1.8× 32 0.3× 140 1.3× 95 1.0× 122 1.3× 47 994
Xianbao Wang China 19 440 1.5× 41 0.4× 81 0.8× 82 0.8× 248 2.6× 25 975
Yinju Hao China 18 353 1.2× 124 1.1× 98 0.9× 19 0.2× 61 0.6× 41 779
Tianfei Luo China 15 501 1.7× 76 0.7× 135 1.3× 28 0.3× 200 2.1× 26 848

Countries citing papers authored by Xiufeng Ye

Since Specialization
Citations

This map shows the geographic impact of Xiufeng Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiufeng Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiufeng Ye more than expected).

Fields of papers citing papers by Xiufeng Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiufeng Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiufeng Ye. The network helps show where Xiufeng Ye may publish in the future.

Co-authorship network of co-authors of Xiufeng Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xiufeng Ye. A scholar is included among the top collaborators of Xiufeng Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiufeng Ye. Xiufeng Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Xiaoyu, Heng He, Dongchao Shen, et al.. (2025). Usefulness of Serum NOX4 as a Potential Biomarker to Predict Early Neurological Deterioration and Poor Outcome of Spontaneous Intracerebral Hemorrhage: A Prospective Observational Study. Neuropsychiatric Disease and Treatment. Volume 21. 295–307. 1 indexed citations
3.
Ye, Xiufeng, et al.. (2025). Utility of Serum Occludin as a Prognostic Biomarker of Severe Traumatic Brain Injury and Mediation Role of Acute Lung Injury: A Two-Center Prospective Cohort Study. International Journal of General Medicine. Volume 18. 3525–3546. 2 indexed citations
4.
Cheng, Yue, Shijie Li, Yongying Hou, et al.. (2023). Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions. Cellular Signalling. 109. 110754–110754. 9 indexed citations
5.
Li, Haili, Xubin Zheng, Jing Gao, et al.. (2022). Whole transcriptome analysis reveals non-coding RNA's competing endogenous gene pairs as novel form of motifs in serous ovarian cancer. Computers in Biology and Medicine. 148. 105881–105881. 14 indexed citations
6.
Cui, Hanwei, Min Tian, Hai Yang, et al.. (2022). ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. Journal of Cancer. 13(8). 2397–2412. 11 indexed citations
7.
Yi, Qian, Hanwei Cui, Yi Liao, et al.. (2021). A minor review of microRNA-338 exploring the insights of its function in tumorigenesis. Biomedicine & Pharmacotherapy. 139. 111720–111720. 5 indexed citations
8.
Liu, Xueyan, Xubin Zheng, Jun Wang, et al.. (2020). A long non‐coding RNA signature for diagnostic prediction of sepsis upon ICU admission. SHILAP Revista de lepidopterología. 10(3). e123–e123. 25 indexed citations
9.
Wan, Weijun, Yongying Hou, Ke Wang, et al.. (2019). The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Cell Death and Disease. 10(3). 248–248. 38 indexed citations
10.
Hou, Yongying, et al.. (2018). Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats. Genes & Diseases. 5(3). 245–255. 229 indexed citations
11.
Zhang, Hongling, Xuhong Chen, Dongming Li, et al.. (2017). DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression. Oncology Reports. 38(1). 377–383. 15 indexed citations
12.
Wan, Dan, et al.. (2016). Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Research Bulletin. 121. 255–262. 110 indexed citations
13.
Ye, Xiufeng, et al.. (2016). [Grape seed proanthocyanidins inhibits the invasion and migration of A549 lung cancer cells].. PubMed. 32(2). 173–6. 4 indexed citations
14.
Sun, Bo, et al.. (2015). Up-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancer.. PubMed. 8(1). 856–61. 24 indexed citations
15.
Sun, Bo, Xiufeng Ye, Yuan Li, & Weiyuan Zhang. (2015). Lgr5 is a potential prognostic marker in patients with cervical carcinoma.. PubMed. 8(2). 1783–9. 9 indexed citations
16.
Ye, Xiufeng. (2012). Role of autophagy in inhibition of proliferation of human umbilical vein endothelial cells by ursolic acid. Zhongguo shengwuzhipinxue zazhi. 1 indexed citations
17.
He, Lin, et al.. (2012). Effects of Emodin Extracted from Chinese Herbs on Proliferation of Non-small Cell Lung Cancer and Underlying Mechanisms. Asian Pacific Journal of Cancer Prevention. 13(4). 1505–1510. 36 indexed citations
18.
Yu, Li, et al.. (2012). Pathologic features and clinical outcome of central neurocytoma: analysis of 15 cases. Chinese Journal of Cancer Research. 24(4). 284–290. 12 indexed citations
19.
Ye, Xiufeng, et al.. (2008). Clinicopathological features of extraskeletal myxoid chondrosarcoma: An analysis of 9 cases. Chinese Journal of Cancer Research. 20(3). 230–236. 2 indexed citations
20.
Xu, Hairong, et al.. (2002). Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats.. PubMed. 23(8). 739–44. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026